December 11, 2012 | Author: Saeed Qureshi

A New Crescent-shaped Spindle for Drug Dissolution Testing—But Why a New Spindle? (Link).

Crescent-shape spindle: Facts sheet (Link)

Advantages of using the crescent shape spindles for drug dissolution testing (Link)

The following links are for the short video clips demonstrating comparative operations of the paddle and the crescent-shaped spindles.

Using a disintegrating tablet: Paddle and Crescent-shape spindle

Using a non-disintegrating tablet: Paddle and Crescent-shape spindle

Note: Dimensions may appear slightly distorted

On-site training/demonstration can be arranged. Post-graduate/doctoral fellows who are interested in using the crescent-shaped spindles for their ongoing research projects may request samples.

For further information and purchase inquiries, please contact by sending an email to (sales@pharmacomechanics.com) or call at: 1-613-797-9815.

There are about 500+ dissolution methods listed in the FDA database and about 600+ methods (monographs) in the USP. In addition to these, there are many more, perhaps in the hundreds, dissolution methods described in the literature. Moreover, as part of new product development exercises, it is a common and expected practice to develop additional new or revised methods.

It may be interesting to note that the objective of drug dissolution testing has never been to develop methods but to determine/estimate drug dissolution/release characteristics of products. By developing drug and/or product-specific dissolution tests, one, in fact, would never know or determine the actual dissolution characteristics of any product. The current practices of method development simply defeat the purpose of products evaluation.

For products evaluation, one requires a test/method which is independently developed and established. Therefore, current practices of method developments are scientifically invalid and useless and a waste of time and resources.

Using the crescent shape spindle with a common set of experimental conditions is suggested to address the current difficulties. The suggested approach practically eliminates the need for method developments, particularly product dependent, and provides a scientifically sound and valid drug dissolution testing and product evaluation approach (e.g., see link, link2).

The following links may be useful for further information regarding the difficulties of the current practices:

  • Drug Dissolution Testing – A serious concern! (link)
  • Costly mistake formulators/analysts often make, i.e., developing a product dependent dissolution test (link)
  • Selecting a Dissolution Apparatus – Some Practical Considerations (link).
  • (Developing) a discriminatory vs. bio-relevant test (link)
  • Method Validation: A Unique Problem Concerning the Drug Dissolution Testing (link)
  • Where does 20% of the drug go? (link)
  • Dissolution method development – a practice that causes confusion and hinders in product evaluation. (link)
  • Drug Dissolution Testing Mosaic. (link)
  • Product dependent dissolution testing – a scientifically invalid practice. (link)
  • How to conduct a dissolution test? A simple question but confusing answers. (link)
  • An incorrect reason for developing and conducting a dissolution test. (link)
  • Method development practices: Are these achieving their intended purpose? (link)
  • Dissolution method development – what it is not! (link)
  • Generics and discriminatory dissolution tests (link)
  • Validation (Method/Apparatus) Practices (link).
  • Selecting an apparatus and its associated experimental conditions for testing (link).
  • The science of drug dissolution testing: Testers or apparatuses, experimental conditions, and interpretation of results – A systematic approach for learning (link)